MARKET

MENS

MENS

Jyong Biotech Ltd.
NASDAQ
29.19
-0.06
-0.21%
Pre Market: 28.98 -0.21 -0.72% 08:05 12/05 EST
OPEN
28.80
PREV CLOSE
29.25
HIGH
30.00
LOW
26.61
VOLUME
79
TURNOVER
--
52 WEEK HIGH
67.00
52 WEEK LOW
6.01
MARKET CAP
2.22B
P/E (TTM)
-735.2645
1D
5D
1M
3M
1Y
5Y
1D
Jyong Biotech signs MOU with Vietnam pharmaceutical distributor
TipRanks · 1d ago
Jyong Biotech Enters Into Non-Binding MOU With Vietnam‑Based Pharmaceutical Distribution Company To Evaluate Development And Commercialization Of MCS‑2 In Vietnam
Benzinga · 1d ago
JYONG BIOTECH EXPANDS REGIONAL PARTNERSHIPS, SIGNS MOU WITH A VIETNAM PHARMACEUTICAL DISTRIBUTOR FOR MCS‑2 MARKET ENTRY
Reuters · 1d ago
Leggett & Platt, New Fortress Energy, Bausch Health Companies And Other Big Stocks Moving Higher On Monday
Benzinga · 4d ago
Weekly Report: what happened at MENS last week (1124-1128)?
Weekly Report · 4d ago
Jyong Biotech: Speculative BPH And Prostate Cancer Prevention Story
Seeking Alpha · 11/27 12:18
Jyong Biotech signs non-binding LOI with South Korean pharma company
TipRanks · 11/24 13:45
Jyong Biotech Signs MoU With South Korean Pharmaceutical Company To Review, Evaluate Licensing, Development Of Jyong Biotech's Plant-Derived New Drug MCS-2
Benzinga · 11/24 13:35
More
About MENS
Jyong Biotech Ltd is a Taiwan-based science-driven biotechnology company. The Company is mainly engaged in developing and commercializing innovative and differentiated new drugs (plant-derived) mainly specializing in the treatment of urinary system diseases, with an initial focus on the markets of the United States (U.S.), the European Union (EU), and Asia. The Company has been developing a series of botanical drug candidates, including primary botanical drug candidate of MCS-2, another clinical-stage botanical drug candidate of PCP, and other preclinical-stage botanical drug candidates. MCS-2 is a new botanical drug candidate developed for treatment of benign prostate hyperplasia/lower urinary tract symptoms (BPH/LUTS). PCP is a new botanical drug candidate developed for the prevention of prostate cancer.

Webull offers Jyong Biotech Ltd. stock information, including NASDAQ: MENS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, MENS stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading MENS stock methods without spending real money on the virtual paper trading platform.